{"id":69,"date":"2013-07-15T10:39:18","date_gmt":"2013-07-15T09:39:18","guid":{"rendered":"http:\/\/www.vision-laser.fr\/?page_id=69"},"modified":"2020-12-15T11:42:05","modified_gmt":"2020-12-15T10:42:05","slug":"traitement-medico-chirurgical-du-glaucome","status":"publish","type":"page","link":"http:\/\/www.vision-laser.fr\/en\/le-glaucome\/traitement-medico-chirurgical-du-glaucome\/","title":{"rendered":"Glaucoma treatment: the medical-surgical process"},"content":{"rendered":"
\n

Glaucoma treatment aims to lower eye pressure to reach a target pressure<\/strong>.
\nTarget pressure is the pressure under treatment that prevents progression or the appearance of visual field deficits.
\nA 20% reduction in initial pressure is considered sufficient in most cases.
\nA 25% reduction in pressure reduces the risk of progression by 45%.
\nIn the case of advanced glaucoma, the pressure must be less than 18 mm Hg and in some cases lower.
\nAny diagnosed glaucoma must be treated either with eye drops, or with Laser treatment<\/a>, or with surgery.<\/p>\n

Medical treatment<\/h2>\n

Almost always in the form of eye drops which must be instilled regularly for better effectiveness.<\/p>\n

The choice of eye drops prescribed as first-line treatment depends on its tolerance, its efficacy and its contraindications and adverse effects.<\/p>\n

    \n
  • Certains agissent en baissant la s\u00e9cr\u00e9tion de l\u2019humeur aqueuse de l\u2019\u0153il :\n
      \n
    • Collyres b\u00eata bloquants (Timoptol, Carteol, Betoptic\u2026)
      \r\nMais il faudra au pr\u00e9alable s\u2019assurer de l\u2019absence de contre-indications (maladie cardiaque de la conduction, asthme, diab\u00e8te insulinod\u00e9pendant etc.\u2026).
      \r\nIls sont le plus souvent prescrits en premi\u00e8re intention \u00e0 raison d\u2019une fois ou deux par jour.<\/li>\n
    • Certains collyres sont des inhibiteurs de l\u2019anhydrase carbonique dorzolamide (Trusopt, Azopt)<\/li>\n
    • Citons \u00e9galement les collyres alpha 2-agoniste (Alphagan, Lumigan …)<\/li>\n<\/ul>\n<\/li>\n
    • D\u2019autres collyres agissent au contraire en augmentant l\u2019\u00e9limination de l\u2019humeur aqueuse :\n
        \n
      • Collyres Adr\u00e9naline et d\u00e9riv\u00e9s (Epinephrine)<\/li>\n
      • Collyres Prostaglandine (Xalatan, Travatan) tr\u00e8s prescrits.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n

        These treatments can cause a change in eye color, eyelash changes and, like all other eye drops, eye irritation upon instillation or even allergies.<\/p>\n

        Finally, let us add that each class can be combined with another in the same bottle in order to increase effectiveness:<\/p>\n

          \n
        • Beta blocker and pilocarpine (CARPILO, TIMPILO),<\/li>\n
        • Anhydrase inhibitor and adrenergic antagonist (COSOPT),<\/li>\n
        • Prostaglandin and beta-blocker (XALACOM).<\/li>\n<\/ul>\n

          In practice, beta-blocker eye drops are often prescribed as a first-line treatment, but some people also prefer to use a prostaglandin because of its lower risk of side effects.<\/p>\n

          Glaucoma Treatment: Surgical Mode<\/h2>\n

          Glaucoma treatment by surgery, although rarer, remains the last resort when medical or laser treatment has failed (increased pressure, worsening of the visual field, treatment not followed).<\/p>\n

          When treating glaucoma by surgery, the operation is performed either on an outpatient basis or after a short hospitalization.<\/p>\n

          It involves trabeculectomy or deep sclerectomy.<\/p>\n

          Both techniques create an additional passageway for the evacuation of aqueous humor.<\/p>\n

          Unlike cataract surgery, during which vision returns quickly, glaucoma surgery results in poor vision in the days that follow, which lasts for a few days.<\/p>\n

          Furthermore, it does not repair damage to the optic nerve that has been permanently destroyed.<\/p>\n

          In expert hands, the success rate of glaucoma surgery on previously unoperated eyes is approximately 90% at 2 years.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

          Le traitement du glaucome vise \u00e0 faire baisser la tension oculaire pour atteindre une pression cible. La pression cible est la pression sous traitement qui permet de pr\u00e9venir la progression ou l\u2019apparition de d\u00e9ficits du champ visuel. On consid\u00e8re qu\u2019une diminution de 20 % de la pression initiale est le plus souvent suffisante. Une diminution […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":63,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-69","page","type-page","status-publish","hentry"],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"http:\/\/www.vision-laser.fr\/en\/wp-json\/wp\/v2\/pages\/69","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.vision-laser.fr\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/www.vision-laser.fr\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/www.vision-laser.fr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/www.vision-laser.fr\/en\/wp-json\/wp\/v2\/comments?post=69"}],"version-history":[{"count":9,"href":"http:\/\/www.vision-laser.fr\/en\/wp-json\/wp\/v2\/pages\/69\/revisions"}],"predecessor-version":[{"id":943,"href":"http:\/\/www.vision-laser.fr\/en\/wp-json\/wp\/v2\/pages\/69\/revisions\/943"}],"up":[{"embeddable":true,"href":"http:\/\/www.vision-laser.fr\/en\/wp-json\/wp\/v2\/pages\/63"}],"wp:attachment":[{"href":"http:\/\/www.vision-laser.fr\/en\/wp-json\/wp\/v2\/media?parent=69"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}